• PDA TR 79

PDA TR 79

  • Technical Report No. 79 (TR 79) Particulate Matter Control in Difficult to Inspect Parenterals
  • Report / Survey by Parenteral Drug Association, 03/01/2018
  • Category: PDA

$325.00 $163.00

PDA Technical Report No. 79, Particulate Matter Control in Difficult to Inspect Parenterals describes best practices for difficult to inspect parenteral (DIP) product lifecycle management, destructive testing, and trending to supplement portions of the guidance given in USP General Chapter<1790>: Visible Particulates in Injection. In 2015, the PDA Task Force on Particulate Matter Control in Difficult to Inspect Parenterals initiated an industry survey on DIP products. literature, pharmacopeial references, and the collective expertise of Task Force contributors form the basis for the information provided in this technical report. This Technical Report is intended to provide logical pathways to DIP product inspection and testing to support continual process improvement in the industry.
PDF

All of our standards document are available in PDF (Portable Document Format), an electronic, downloadable format.You will be able to download the file in your account downloads.

Multi-User Access

After purchasing, you have the ability to assign each license to a specific user.

Printable

At any time, you are permitted to make printed copies for your and your members' reference use.

PDA TR 50

PDA TR 50

Technical Report No. 50 (TR 50) Alternative Methods for Mycoplasma Testing..

$163.00 $325.00

PDA TR 51

PDA TR 51

Technical Report No. 51 (TR 51) Biological Indicators for Gas and Vapor-Phase Decontamination Proces..

$163.00 $325.00

PDA TR 53

PDA TR 53

Technical Report No. 53 (TR 53) Guidance for Industry: Stability Testing to Support Distribution of ..

$163.00 $325.00

PDA TR 52

PDA TR 52

Technical Report No. 52 (TR 52) Guidance for Good Distribution Practices (GDPs) For the Pharmaceutic..

$163.00 $325.00